Alex R. Rinehart

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women”.

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

New England Journal of Medicine(2021)10.1056/nejmoa2101016

N/A

8.3DataRank · unranked

869 citations

Deborah Donnell, Meredith E. Clement, Brett Hanscom, Leslie Cottle, Lara E. Coelho +60 more

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

The Lancet(2022)10.1016/s0140-6736(22)00538-4

N/A

7.4DataRank · unranked

552 citations

James P. Hughes, Peter Bock, Samuel Gurrion Ouma, Portia Hunidzarira, Dishiki Kalonji +95 more

Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00261-8

N/A

2.0DataRank · unranked

68 citations

Brett Hanscom, Meredith E. Clement, Trần Việt Hà, Esper G. Kallás, Manya Magnus +25 more

Dynamic choice HIV prevention with cabotegravir long-acting injectable in rural Uganda and Kenya: a randomised trial extension

The Lancet HIV(2024)10.1016/s2352-3018(24)00235-2

N/A

1.4DataRank · unranked

42 citations

Laura B. Balzer, James Ayieko, Jane Kabami, Elijah Kakande, Gabriel Chamie +11 more

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00200-x

N/A

0.580DataRank · unranked

14 citations

Brett Hanscom, Zhe Wang, Steven A. Safren, Christina Psaros, Deborah Donnell +61 more

HPTN 083‐02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study

Journal of the International AIDS Society(2024)10.1002/jia2.26252

N/A

0.417DataRank · unranked

9 citations

Georgia R. Goodman, Jasper S. Lee, Whitney S. Rice, Colleen F. Kelley, Temitope Oyedele +18 more

“It’s already in your body and it’s preventing”: a qualitative study of African female adolescent’s acceptability and preferences for proxy HIV prevention methods in Cape Town, South Africa

BMC Public Health(2023)10.1186/s12889-023-16955-3

N/A

0.341DataRank · unranked

5 citations

Katherine Gill, Melissa Wallace, Millicent Atujuna, Menna Duyver, P. Z. Ngcobo +5 more

Pharmacologic evaluation of delayed long-acting cabotegravir administration among cisgender women in HPTN 084

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.00994-24

N/A

0.165DataRank · unranked

2 citations

Kelong Han, Brett Hanscom, Xu Guo, Estelle Piwowar-Manning, Craig W. Hendrix +14 more

Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis

Microbiology Spectrum(2024)10.1128/spectrum.00307-24

N/A

0DataRank · unranked

9 citations

Estelle Piwowar-Manning, Amber Moser, Tinia Hill, Shahnaz Ahmed, Vanessa Cummings +15 more

HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084

AIDS Research and Human Retroviruses(2024)10.1089/aid.2024.0049

N/A

0DataRank · unranked

5 citations

Deborah Persaud, Estelle Piwowar‐Manning, Paul Richardson, Joseph Szewczyk, Mark A. Marzinke +19 more

Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084

Journal of the International AIDS Society(2025)10.1002/jia2.26401

N/A

0DataRank · unranked

17 citations

Brett Hanscom, Xu Guo, Clemensia Nkabiito, Patricia Mandima, Patricia Ntege Nahirya +17 more

Estimation of Prevention-Effective CAB-LA Concentrations Among Men Who Have Sex With Men (MSM) and Transgender Women (TGW) in HPTN 083

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf561

N/A

0DataRank · unranked

2 citations

Mark A. Marzinke, Xinnong Li, Deborah Donnell, Robert R. Bies, Craig W. Hendrix +16 more

Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial

UNC Libraries(2025)10.17615/8yt1-yt24

N/A

0DataRank · unranked

1 citations

Beatriz Grinsztejn, Omar Sued, Adeola Adeyeye, Estelle Piwowar‐Manning, Meredith E. Clement +26 more

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial

UNC Libraries(2025)10.17615/9zee-gb05

N/A

0DataRank · unranked

0 citations

Beatriz Grinsztejn, Mark A. Marzinke, Brett Hanscom, Alex R. Rinehart, Susan H. Eshleman +26 more

Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf645

N/A

0DataRank · unranked

0 citations

Jessica M. Fogel, Mark A. Marzinke, Elias K. Halvas, Urvi M. Parikh, John W. Mellors +15 more

An open‐label, randomized crossover study to evaluate the acceptability and preference for contraceptive options in female adolescents, 15 to 19 years of age in Cape Town, as a proxy for HIV prevention methods (UChoose)

Journal of the International AIDS Society(2020)10.1002/jia2.25626

N/A

0DataRank · unranked

48 citations

Anna‐Ursula Happel, Tanya Pidwell, Andrea S. Mendelsohn, Menna Duyver, Leigh F. Johnson +14 more

Evaluation of pharmacokinetic interactions between long‐acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084

Journal of the International AIDS Society(2025)10.1002/jia2.70056

N/A

0DataRank · unranked

0 citations

Brett Hanscom, Daniel Haines, Kimberly K. Scarsi, Yaw Agyei, Estelle Piwowar‐Manning +17 more

Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)

eScholarship (California Digital Library)(2020)10.17615/m2r7-rg29

N/A

0DataRank · unranked

28 citations

Ian Frank, Susan H. Eshleman, Ken Ho, Robert A. Salata, Jorge Santana +24 more

Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab152

N/A

0DataRank · unranked

132 citations

Beatriz Grinsztejn, Jessica M. Fogel, Estelle Piwowar‐Manning, Maoji Li, Lei Weng +25 more

Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab576

N/A

0DataRank · unranked

69 citations

Jessica M. Fogel, Estelle Piwowar‐Manning, Gordon Chau, Vanessa Cummings, Yaw Agyei +28 more

Identification of Novel UGT1A1 Variants Including UGT1A1 454C>A through the Genotyping of Healthy Participants of the HPTN 077 Study

ACS Pharmacology & Translational Science(2021)10.1021/acsptsci.0c00181

N/A

0DataRank · unranked

2 citations

Allyson N. Hamlin, Sue Li, Beatriz Grinsztejn, Halima Dawood, Albert Liu +14 more

HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac415

N/A

0DataRank · unranked

36 citations

Jessica M. Fogel, Elias K. Halvas, Estelle Piwowar‐Manning, Mark A. Marzinke, Ryan Kofron +25 more

Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.00053-23

N/A

0DataRank · unranked

29 citations

Jessica M. Fogel, Zhe Wang, Estelle Piwowar‐Manning, Ryan Kofron, Amber Moser +24 more

Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis

New England Journal of Medicine(2024)10.1056/nejmc2402088

N/A

0DataRank · unranked

35 citations

Sinéad Delany‐Moretlwe, Jessica M. Fogel, Mark A. Marzinke, Estelle Piwowar-Manning, Paul A. Richardson +15 more